Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Intranasal Introduction of Fc-Fused Interleukin-7 Provides Long-Lasting Prophylaxis against Lethal Influenza Virus Infection.

Kang MC, Choi DH, Choi YW, Park SJ, Namkoong H, Park KS, Ahn SS, Surh CD, Yoon SW, Kim DJ, Choi JA, Park Y, Sung YC, Lee SW.

J Virol. 2015 Dec 9;90(5):2273-84. doi: 10.1128/JVI.02768-15.

2.

Repeated Low-Dose Influenza Virus Infection Causes Severe Disease in Mice: a Model for Vaccine Evaluation.

Song Y, Wang X, Zhang H, Tang X, Li M, Yao J, Jin X, Ertl HC, Zhou D.

J Virol. 2015 Aug;89(15):7841-51. doi: 10.1128/JVI.00976-15. Epub 2015 May 20.

3.

New Orf virus (Parapoxvirus) recombinant expressing H5 hemagglutinin protects mice against H5N1 and H1N1 influenza A virus.

Rohde J, Amann R, Rziha HJ.

PLoS One. 2013 Dec 20;8(12):e83802. doi: 10.1371/journal.pone.0083802. eCollection 2013.

4.

Cleavage activation of human-adapted influenza virus subtypes by kallikrein-related peptidases 5 and 12.

Hamilton BS, Whittaker GR.

J Biol Chem. 2013 Jun 14;288(24):17399-407. doi: 10.1074/jbc.M112.440362. Epub 2013 Apr 23.

5.

Avian H5N1 influenza: In or out flew-enza?

Morgan JG.

Bioeng Bugs. 2012 May-Jun;3(3):145-6. doi: 10.4161/bbug.20190. Epub 2012 May 1. No abstract available.

6.

Ferretting out the facts behind the H5N1 controversy.

Sleator RD.

Bioeng Bugs. 2012 May-Jun;3(3):139-43. doi: 10.4161/bbug.19943. Epub 2012 May 1.

7.

siRNA for Influenza Therapy.

Barik S.

Viruses. 2010 Jul;2(7):1448-57. doi: 10.3390/v2071448. Epub 2010 Jul 9.

8.

Disruption of the viral polymerase complex assembly as a novel approach to attenuate influenza A virus.

Mänz B, Götz V, Wunderlich K, Eisel J, Kirchmair J, Stech J, Stech O, Chase G, Frank R, Schwemmle M.

J Biol Chem. 2011 Mar 11;286(10):8414-24. doi: 10.1074/jbc.M110.205534. Epub 2010 Dec 23.

9.

Human genomics and preparedness for infectious threats.

Dowling NF, Gwinn M, Mawle A.

Genome Med. 2009 Dec 29;1(12):119. doi: 10.1186/gm119.

10.

Evidence for a novel gene associated with human influenza A viruses.

Clifford M, Twigg J, Upton C.

Virol J. 2009 Nov 16;6:198. doi: 10.1186/1743-422X-6-198.

11.

Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.

Wunderlich K, Mayer D, Ranadheera C, Holler AS, Mänz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M.

PLoS One. 2009 Oct 20;4(10):e7517. doi: 10.1371/journal.pone.0007517.

12.

Design and validation of real-time reverse transcription-PCR assays for detection of pandemic (H1N1) 2009 virus.

Pabbaraju K, Wong S, Wong AA, Appleyard GD, Chui L, Pang XL, Yanow SK, Fonseca K, Lee BE, Fox JD, Preiksaitis JK.

J Clin Microbiol. 2009 Nov;47(11):3454-60. doi: 10.1128/JCM.01103-09. Epub 2009 Sep 2.

13.

Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice.

Maines TR, Jayaraman A, Belser JA, Wadford DA, Pappas C, Zeng H, Gustin KM, Pearce MB, Viswanathan K, Shriver ZH, Raman R, Cox NJ, Sasisekharan R, Katz JM, Tumpey TM.

Science. 2009 Jul 24;325(5939):484-7. doi: 10.1126/science.1177238. Epub 2009 Jul 2.

Items per page

Supplemental Content

Write to the Help Desk